POLAR CAPITAL HOLDINGS PLC – Neurocrine Biosciences, Inc. Transaction History
POLAR CAPITAL HOLDINGS PLC portfolio value:
$18.47M
portfolio value
POLAR CAPITAL HOLDINGS PLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -77.82% | -610.34K shares | -57.97M | $106.21 | 173.94K |
| Q2 2022 | share | Increase | +3.29% | 25K shares | 5.26M | $97.48 | 784.28K |
| Q1 2022 | share | Increase | +2114.50% | 725K shares | 68.26M | $93.75 | 759.28K |
| Q4 2021 | share | Increase | +15.00% | 4.47K shares | 60K | $84.63 | 34.28K |
| Q3 2021 | share | Decrease | -81.82% | -134.15K shares | -13.09M | $95.91 | 29.81K |
| Q2 2021 | share | Increase | +27.29% | 35.15K shares | 3.43M | $97.32 | 163.97K |
| Q1 2021 | share | Increase | +4.89% | 6K shares | 755K | $97.25 | 128.81K |
| Q4 2020 | share | Increase | 0.00% | 122.81K shares | 11.77M | $95.85 | 122.81K |